7th Circ. Blocks Boehringer Workers' Depos In Pradaxa MDL

Law360, New York (January 03, 2014, 9:06 PM ET) -- The Seventh Circuit on Thursday temporarily blocked Germany-based Boehringer Ingelheim International GmbH employees from being deposed in the U.S. in personal injury multidistrict litigation over the blood thinner Pradaxa, after the drugmaker argued a lower court overstepped its authority.

In a Dec. 9 order penalizing the company for discovery abuses, an Illinois federal judge ordered BII and U.S. unit Boehringer Ingelheim Pharmaceuticals Inc. to make foreign employees available for depositions in New York City or elsewhere in the U.S. The judge hit the drugmakers with a...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers